Financhill
Sell
38

ZTS Quote, Financials, Valuation and Earnings

Last price:
$163.85
Seasonality move :
-0.46%
Day range:
$163.53 - $166.39
52-week range:
$144.80 - $200.53
Dividend yield:
1.05%
P/E ratio:
30.99x
P/S ratio:
8.23x
P/B ratio:
14.21x
Volume:
6.1M
Avg. volume:
2.7M
1-year change:
-15.31%
Market cap:
$74.4B
Revenue:
$8.5B
EPS (TTM):
$5.32

Earnings Data

Next earnings date for ZTS
Feb 13
2025
Most recent earnings per share
$1.50
Beat by $0.04
(Nov 4/2024)
Consensus Estimate
$1.46
(Nov 4/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ZTS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/13/2025 Q4 $2.3B -- -- $1.36 --
11/04/2024 Q3 $2.3B $2.4B $1.50 $1.46 $0.04
08/06/2024 Q2 $2.3B $2.4B $1.37 $1.48 -$0.11
05/02/2024 Q1 $2.1B $2.2B $1.31 $1.34 -$0.03
02/13/2024 Q4 $2.2B $2.2B $1.14 $1.32 -$0.18
11/02/2023 Q3 -- -- $1.29 $1.36 -$0.07
08/08/2023 Q2 -- -- $1.45 $1.31 $0.14
05/04/2023 Q1 -- -- $1.19 $1.25 -$0.06
02/14/2023 Q4 -- -- $0.99 $1.15 -$0.16
11/03/2022 Q3 -- -- $1.13 $1.24 -$0.11
08/04/2022 Q2 -- -- $1.12 $1.22 -$0.10
05/05/2022 Q1 -- -- $1.26 $1.22 $0.04
02/15/2022 Q4 -- -- $0.87 $0.96 -$0.09
11/04/2021 Q3 -- -- $1.16 $1.11 $0.05
08/05/2021 Q2 -- -- $1.07 $1.09 -$0.02
05/06/2021 Q1 -- -- $1.17 $1.04 $0.13
02/16/2021 Q4 -- -- $0.75 $0.87 -$0.12
11/05/2020 Q3 -- -- $1.00 $0.92 $0.08
08/06/2020 Q2 -- -- $0.79 $0.65 $0.14
05/06/2020 Q1 -- -- $0.88 $0.87 $0.01
02/13/2020 Q4 -- -- $0.80 $0.88 -$0.08
11/07/2019 Q3 -- -- $0.90 $0.89 $0.01
08/06/2019 Q2 -- -- $0.90 $0.82 $0.08
05/02/2019 Q1 -- -- $0.88 $0.79 $0.09
02/14/2019 Q4 -- -- $0.79 $0.77 $0.02
11/01/2018 Q3 -- -- $0.83 $0.77 $0.06
08/02/2018 Q2 -- -- $0.77 $0.70 $0.07
05/02/2018 Q1 -- -- $0.75 $0.69 $0.06
02/15/2018 Q4 -- -- $0.69 $0.66 $0.03
11/02/2017 Q3 -- -- $0.65 $0.62 $0.03
08/08/2017 Q2 -- -- $0.53 $0.53 $0.00
05/04/2017 Q1 -- -- $0.53 $0.48 $0.05
02/16/2017 Q4 -- -- $0.47 $0.45 $0.02
11/02/2016 Q3 -- -- $0.52 $0.46 $0.06
08/03/2016 Q2 -- -- $0.49 $0.44 $0.05
05/04/2016 Q1 -- -- $0.48 $0.41 $0.07
02/16/2016 Q4 -- -- $0.43 $0.39 $0.04
11/03/2015 Q3 -- -- $0.50 $0.40 $0.10
08/04/2015 Q2 -- -- $0.43 $0.38 $0.05
05/05/2015 Q1 -- -- $0.41 $0.37 $0.04
02/11/2015 Q4 -- -- $0.40 $0.36 $0.04

Zoetis Earnings Questions

  • How Much did Zoetis Generate in Revenue Last Quarter?

    Zoetis reported $2.4B worth of top line sales in its most recent quarter.

  • Did Zoetis Beat Earnings Last Quarter?

    Zoetis announced earnings per share of $1.50 which represents a beat of analyst forecast a $1.46 per share.

  • Is Zoetis Profitable?

    Zoetis reported $1.7B that represents $3.72 per share over the last quarter.

  • What is the Analyst Consensus for Zoetis EPS Next Year?

    Zoetis's earnings are forecast to grow from $5.07 per share to $5.41 per share next year representing an increase of 15.9%.

  • When is Zoetis's Earnings Date?

    Zoetis's next earnings date is February 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 2.15% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 10.25% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.43% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock